- Two year agreement supports Abcam’s range of kits and other non-antibody products
|Over 500 kits now available|
Abcam has extended its global licensing agreement with Tepnel Life Sciences. The two year deal means that Abcam will continue to distribute Tepnel’s Diaclone range of products to scientists worldwide.
The agreement supports Abcam’s growing range of non-antibody products, which now includes proteins, peptides, kits, slides and lysates.